These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26004200)

  • 21. Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72.
    Ishiura H; Tsuji S
    J Neurogenet; 2015; 29(2-3):85-94. PubMed ID: 26540641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis.
    Irwin DJ; McMillan CT; Brettschneider J; Libon DJ; Powers J; Rascovsky K; Toledo JB; Boller A; Bekisz J; Chandrasekaran K; Wood EM; Shaw LM; Woo JH; Cook PA; Wolk DA; Arnold SE; Van Deerlin VM; McCluskey LF; Elman L; Lee VM; Trojanowski JQ; Grossman M
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):163-9. PubMed ID: 23117491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.
    Riku Y; Duyckaerts C; Boluda S; Plu I; Le Ber I; Millecamps S; Salachas F; ; Yoshida M; Ando T; Katsuno M; Sobue G; Seilhean D
    Acta Neuropathol; 2019 Nov; 138(5):783-793. PubMed ID: 31144027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.
    Liu EY; Russ J; Wu K; Neal D; Suh E; McNally AG; Irwin DJ; Van Deerlin VM; Lee EB
    Acta Neuropathol; 2014 Oct; 128(4):525-41. PubMed ID: 24806409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.
    Mori K; Weng SM; Arzberger T; May S; Rentzsch K; Kremmer E; Schmid B; Kretzschmar HA; Cruts M; Van Broeckhoven C; Haass C; Edbauer D
    Science; 2013 Mar; 339(6125):1335-8. PubMed ID: 23393093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study.
    Benussi L; Rossi G; Glionna M; Tonoli E; Piccoli E; Fostinelli S; Paterlini A; Flocco R; Albani D; Pantieri R; Cereda C; Forloni G; Tagliavini F; Binetti G; Ghidoni R
    J Alzheimers Dis; 2014; 38(4):799-808. PubMed ID: 24064469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration.
    Ohki Y; Wenninger-Weinzierl A; Hruscha A; Asakawa K; Kawakami K; Haass C; Edbauer D; Schmid B
    Mol Neurodegener; 2017 Jan; 12(1):6. PubMed ID: 28088213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C9orf72 hexanucleotide repeat expansion in Indian patients with ALS: a common founder and its geographical predilection.
    Shamim U; Ambawat S; Singh J; Thomas A; Pradeep-Chandra-Reddy C; Suroliya V; Uppilli B; Parveen S; Sharma P; Chanchal S; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Keerthipriya M; Mahajan NP; Reddy N; Thomas PT; Sadasivan A; Warrier M; Seth M; Zahra S; Mathur A; Vibha D; Srivastava AK; Nalini A; Faruq M
    Neurobiol Aging; 2020 Apr; 88():156.e1-156.e9. PubMed ID: 32035847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
    Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
    Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis.
    Herdewyn S; Zhao H; Moisse M; Race V; Matthijs G; Reumers J; Kusters B; Schelhaas HJ; van den Berg LH; Goris A; Robberecht W; Lambrechts D; Van Damme P
    Hum Mol Genet; 2012 Jun; 21(11):2412-9. PubMed ID: 22343411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation.
    Bigio EH; Weintraub S; Rademakers R; Baker M; Ahmadian SS; Rademaker A; Weitner BB; Mao Q; Lee KH; Mishra M; Ganti RA; Mesulam MM
    Neuropathology; 2013 Apr; 33(2):122-33. PubMed ID: 22702520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the genetics of the ALS-FTLD complex.
    Morris HR; Waite AJ; Williams NM; Neal JW; Blake DJ
    Curr Neurol Neurosci Rep; 2012 Jun; 12(3):243-50. PubMed ID: 22477152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients.
    Prudencio M; Gonzales PK; Cook CN; Gendron TF; Daughrity LM; Song Y; Ebbert MTW; van Blitterswijk M; Zhang YJ; Jansen-West K; Baker MC; DeTure M; Rademakers R; Boylan KB; Dickson DW; Petrucelli L; Link CD
    Hum Mol Genet; 2017 Sep; 26(17):3421-3431. PubMed ID: 28637276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina.
    Itzcovich T; Xi Z; Martinetto H; Chrem-Méndez P; Russo MJ; de Ambrosi B; Uchitel OD; Nogués M; Silva E; Rojas G; Bagnatti P; Amengual A; Campos J; Rogaeva E; St George-Hyslop P; Allegri R; Sevlever G; Surace EI
    Neurobiol Aging; 2016 Apr; 40():192.e13-192.e15. PubMed ID: 26925510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients.
    Mordes DA; Prudencio M; Goodman LD; Klim JR; Moccia R; Limone F; Pietilainen O; Chowdhary K; Dickson DW; Rademakers R; Bonini NM; Petrucelli L; Eggan K
    Acta Neuropathol Commun; 2018 Jul; 6(1):55. PubMed ID: 29973287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity.
    Gittings LM; Boeynaems S; Lightwood D; Clargo A; Topia S; Nakayama L; Troakes C; Mann DMA; Gitler AD; Lashley T; Isaacs AM
    Acta Neuropathol; 2020 Feb; 139(2):407-410. PubMed ID: 31832771
    [No Abstract]   [Full Text] [Related]  

  • 38. Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion.
    Udine E; DeJesus-Hernandez M; Tian S; das Neves SP; Crook R; Finch NA; Baker MC; Pottier C; Graff-Radford NR; Boeve BF; Petersen RC; Knopman DS; Josephs KA; Oskarsson B; Da Mesquita S; Petrucelli L; Gendron TF; Dickson DW; Rademakers R; van Blitterswijk M
    Acta Neuropathol; 2024 Apr; 147(1):73. PubMed ID: 38641715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration.
    Suh E; Lee EB; Neal D; Wood EM; Toledo JB; Rennert L; Irwin DJ; McMillan CT; Krock B; Elman LB; McCluskey LF; Grossman M; Xie SX; Trojanowski JQ; Van Deerlin VM
    Acta Neuropathol; 2015 Sep; 130(3):363-72. PubMed ID: 26022924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of toxicity in C9FTLD/ALS.
    Gendron TF; Belzil VV; Zhang YJ; Petrucelli L
    Acta Neuropathol; 2014 Mar; 127(3):359-76. PubMed ID: 24394885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.